Medtronic Innovation Center Japan to be opened at Kawasaki KINGSKYFRONT on 1 September 2017
4 August 2017
Medtronic Innovation Center Japan to be opened at Kawasaki KINGSKYFRONT on 1 September 2017. The Center will provide the latest educational programs and services for medical professionals and respond to the needs of medical practitioners through information dissemination.
In Japan’s aging society there is increasing demand for advanced medical technology to be used as a treatment tool and for technologies and products suitable for medical facilities. Medtronic aims to focus on technological innovation in medical care and aims to provide superior products and services, and at the Medtronic Innovation Center, Medtronic will provide wide ranging programs to enable medical staff to use Medtronic's products safely and properly.
The Center will offer wide ranging programs of seminar on minimally invasive surgery, manual training on cardiovascular treatment, simulation training. In addition, Medtronic plans to introduce the latest audio visual system and conference system and exhibits that make full use of CG technology to attain the latest technology, knowledge and information more efficiently and effectively.
As a global leader in medical technology, services and solutions, Medtronic’s plans are based on the concept of Value-based healthcare aimed at achieving compatibility between provision of medical care to improve patient's treatment results and reduction of medical costs based on collaboration with medical institutions, governments, companies, etc., the Medtronic Innovation Center aims to become a base for more effective service development and information dissemination.
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is a global leader in providing healthcare technology, services and solutions aimed at softening pain, restoring health, and extending the lives of people around the world. With more than 90,000 employees worldwide, Medtronic plc contributes to doctors, hospitals and patients in about 160 countries. The company is working on the development of medical technology in collaboration with all its global partners.
In addition, all statements concerning future prospects may be affected by risks and uncertainties as described in the periodic report filed by Medtronic with the USA Securities and Exchange Commission. Actual results may differ markedly from forecasts.